Skip to main content
. Author manuscript; available in PMC: 2011 Dec 21.
Published in final edited form as: Fam Cancer. 2011 Sep;10(3):545–548. doi: 10.1007/s10689-011-9447-9

Table 2.

Associations of PALB2 tagging SNPs with melanoma in melanoma-prone families with CDKN2A mutations

SNPs All families (n=23) Families with PC or PC-related mutations (n=11)
OR (95% CI)1 p1 OR (95% CI) 1 p1
rs240745 0.58 (0.29–1.19) 0.14 0.73 (0.25–2.12) 0.57
rs240744 1.42 (0.59–3.43) 0.44 1.17 (0.39–3.53) 0.78
rs12162020 0.72 (0.33–1.61) 0.43 1.27 (0.44–3.66) 0.66
rs420259 1.30 (0.73–2.32) 0.37 1.60 (0.74–3.48) 0.24
rs513313 1.66 (0.65–4.24) 0.29 1.23 (0.34–4.45) 0.75
rs16940342 1.14 (0.59–2.23) 0.69 1.14 (0.52–2.52) 0.74
rs8058061 0.76 (0.18–3.26) 0.71 1.30 (0.25–6.77) 0.76
rs0843812 0.58 (0.23–1.47) 0.25 0.73 (0.15–3.55) 0.70
rs17806253 0.74 (0.34–1.57) 0.43 0.71 (0.24–2.12) 0.54
rs34514 0.93 (0.49–1.75) 0.82 1.02 (0.40–2.61) 0.96
rs34513 0.88 (0.48–1.61) 0.68 1.24 (0.50–3.04) 0.64
1

ORs and P values are obtained from likelihood ratio test in conditional logistic regression with melanoma as the outcome variable adjusting for age, gender, and CDKN2A status.